retatrutide clinical trial phase Eli Lilly's 3 studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments Pharmaceutical Executive Daily: Eli Lilly

Resistance training two to three times per week, combined with adequate protein intake, sends muscle-building signals that counteract the catabolic effects of caloric restriction

According to the American Diabetes Association's Standards of Medical Care in Diabetes, proper injection technique and systematic site rotation are essential for optimal medication absorption and to prevent lipohypertrophy (thickening of fatty tissue) or lipoatrophy (loss of fatty tissue) at injection sites

adolescent : Someone in that transitional stage of physical and psychological development that begins at the onset of puberty, typically between the ages of 11 and 13, and ends with adulthood

"But if we're really talking about treating obesity, those microdosing doses are not going to be effective for most people, and so I worry people are going to pay for it cause it's cheaper and then it's not going to work for them and they're going to think 'here's one more thing that's not working for me.'" Read more: You need more than Ozempic to fight food addiction

The foundation's annual youth survey found that more than half of all young people aged 12-18 reported being dissatisfied with their bodies in 2024